The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C Bio Buffer ...

Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient according to new ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast period. Major factors driving growth include increased demand for biopharmaceuticals ...

Real-time, in-process understanding Quantitative monitoring of excipient and protein concentration using a single probe in ultrafiltration/diafiltration operations ...

Biopharmaceutical manufacturing may come in a wide variety of forms, but each iteration of unit operation needs to align with a strict amount of operational parameters and structures in order to ...

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market by Product, Technology, Application, End-users and Region - Global Forecast 2025-2030" report has ...

The biopharmaceutical industry has experienced tremendous growth over the last ten years as a result of genetic engineering. The global market for biopharmaceuticals, valued at $48 billion in 2004, ...

Although biopharmaceutical manufacturing covers an extensive range, it is essential that each iteration of a unit operation is in compliance with an unyielding set of operational parameters and ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast period. Major factors driving growth include increased demand for biopharmaceuticals ...